Clinical Trial Update: Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial examined rotating or switching to a different biologic after TNF inhibitor failure in axial spondyloarthritis, and the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Axial Spondyloarthritis | Phase 4 | Status: COMPLETED